We are live on ! Find out more
EBACW

European Biotech Acquisition Corp. Warrant
EBACW

Delisted

EBACW was delisted on the 2nd of March, 2023.

Back to rankings

21 hedge funds and large institutions have $2.06M invested in European Biotech Acquisition Corp. Warrant in 2021 Q2 according to their latest regulatory filings, with 21 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
+21
Holders Change %
–
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
–
Reduced
–
Closed
–
Calls
$1.07M
Puts
–
Net Calls
+$1.07M
Net Calls Change
+$1.07M

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$243K
2
LA
Linden Advisors
New York
+$154K
3
SCM
Suvretta Capital Management
New York
+$93K
4
WP
Woodline Partners
California
+$85.3K
5
MI
MMCAP International
Cayman Islands
+$77.5K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$647K +$62K +66,666 New
AC
2
Athanor Capital
New York
$451K +$43.5K +46,716 New
Citadel Advisors
3
Citadel Advisors
Florida
$251K +$243K +261,666 New
LA
4
Linden Advisors
New York
$165K +$154K +165,999 New
SCM
5
Suvretta Capital Management
New York
$95K +$93K +100,000 New
WP
6
Woodline Partners
California
$88K +$85.3K +91,666 New
SC
7
Sculptor Capital
New York
$66K +$62K +66,666 New
FTCM
8
Fir Tree Capital Management
New York
$48K +$46.5K +49,997 New
MCM
9
Moore Capital Management
New York
$40K +$38.8K +41,666 New
PMAM
10
Picton Mahoney Asset Management
Ontario, Canada
$39K +$38.8K +41,666 New
DCM
11
Dupont Capital Management
Delaware
$32K +$31K +33,332 New
TCM
12
Tenor Capital Management
New York
$32K +$31K +33,333 New
ACA
13
Arena Capital Advisors
California
$24K +$23.3K +25,000 New
SCC
14
Spring Creek Capital
Kansas
$16K +$15.5K +16,666 New
AA
15
AQR Arbitrage
Connecticut
$14K +$13.6K +14,666 New
EAM
16
Exos Asset Management
New York
$14K +$14K +15,100 New
ACM
17
Atalaya Capital Management
New York
$13K +$12.4K +13,333 New
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$11K +$10.3K +11,111 New
VI
19
Vestcor Inc
New Brunswick, Canada
$11K +$10.9K +11,666 New
AA
20
Ancora Advisors
Ohio
$2K +$2.17K +2,332 New
MI
21
MMCAP International
Cayman Islands
$79 +$77.5K +83,333 New

EBACW Hedge Fund Activity: Q2 2021 in Review

21 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in European Biotech Acquisition Corp. Warrant (EBACW) for Q2 2021, worth a combined $2.06M.

Buyers outnumbered sellers: 21 funds opened new EBACW positions and 0 closed out — a net gain of 21 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $243K.

  • 21 institutional investors held European Biotech Acquisition Corp. Warrant (EBACW) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $2.06M of European Biotech Acquisition Corp. Warrant stock for Q2 2021.
  • 21 funds opened new European Biotech Acquisition Corp. Warrant positions in Q2 2021 and 0 closed out, a net change of +21 holders.
  • The largest European Biotech Acquisition Corp. Warrant buyer in Q2 2021 was Citadel Advisors, an estimated $243K added.

Based on aggregated 13F filings for Q2 2021.